Patents by Inventor Martina Muller-Schilling

Martina Muller-Schilling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6770474
    Abstract: The present invention relates to p53 binding regions on a CD95 receptor DNA and to the application of the p53 binding regions to influence apoptosis and/or identify suitable substances therefor.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: August 3, 2004
    Assignee: Deutsches Krebsforschungszentrum
    Inventors: Peter Krammer, Martina Muller-Schilling, Moshe Oren
  • Publication number: 20030157502
    Abstract: Disclosed is a method for determining whether a test compound is effective for a chemotherapy. The inventive method comprises the following steps: a) a DNA sequence is provided, whereby said sequence comprises site AP-1 represented in FIG. 5A as a constituent of a promoter, preferably promoter CD95L, which is functionally linked to a reporter gene or the CD95L gene, b) the DNA sequence a) is brought into contact with the test compound in a cellular assay, and c) activation of the promoter is determined, said activation indicating that the test compound is effective for a chemotherapy.
    Type: Application
    Filed: November 18, 2002
    Publication date: August 21, 2003
    Inventors: Peter Krammer, Soren Eichhorst, Min Li-Weber, Martina Muller-Schilling
  • Publication number: 20020042064
    Abstract: The present invention relates to p53 binding regions on a CD95 receptor DNA and to the application of the p53 binding regions to influence apoptosis and/or identify suitable substances therefor.
    Type: Application
    Filed: April 12, 2001
    Publication date: April 11, 2002
    Applicant: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts
    Inventors: Peter Krammer, Martina Muller-Schilling, Moshe Oren